185 results
Page 3 of 10
8-K
EX-4.1
ws6pppw2jx23g
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
424B5
urgfa6x2tb8k8xzieqn
19 May 20
Prospectus supplement for primary offering
5:29pm
8-K
EX-4.1
5j33mf
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm
8-K
EX-4.2
s1v2yhn0
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm
424B3
delti08ws9lfbk2
30 Dec 19
Prospectus supplement
10:07am
8-K
EX-4.2
exrrg3546kmgmrekqm5
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-4.1
gzi6igrj59usuhulsq8i
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
424B5
kwad7 ansx0cc
13 Dec 19
Prospectus supplement for primary offering
7:59am
424B4
jxg1ad2fk 9n
15 Nov 19
Prospectus supplement with pricing info
12:00am
8-K
EX-4.1
yjrlss n7i
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-4.4
zzfoemlpalwna87k
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-4.3
3rl4foqzzp ua
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-4.2
08d4el
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm